PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2016

Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition.

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 27751939 ↗2016Reported benefit

Inhibition of glycogen synthase kinase 3beta ameliorates triptolide-induced acute cardiac injury by desensitizing mitochondrial permeability transition.

MouseChemical/toxinC57BL/6Jmale

Model: triptolide-induced acute cardiac injury in mice, with corroborating in vitro studies in triptolide-treated H9c2 cardiomyoblasts

Pharmacological inhibition of GSK-3beta with SB 216763 ameliorated triptolide-induced acute cardiac injury in mice and improved cell viability and reduced apoptosis in triptolide-treated H9c2 cells, via prevention of GSK-3beta-mediated cyclophilin F phosphorylation and desensitisation of the mitoch…

Extraction: extract · Supplied extraction confidence: 0.55. Machine-extracted fields require source verification.